Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for ACU.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 13.12M
March 31, 2026 -2.233M
December 31, 2025 8.150M
September 30, 2025 7.081M
June 30, 2025 6.335M
March 31, 2025 -3.337M
December 31, 2024 6.371M
September 30, 2024 8.874M
June 30, 2024 6.898M
March 31, 2024 -10.17M
December 31, 2023 7.238M
September 30, 2023 11.12M
June 30, 2023 2.867M
March 31, 2023 7.676M
December 31, 2022 10.50M
September 30, 2022 -2.437M
June 30, 2022 0.309M
March 31, 2022 -5.479M
December 31, 2021 2.162M
September 30, 2021 2.836M
June 30, 2021 0.479M
March 31, 2021 -0.336M
December 31, 2020 3.98M
September 30, 2020 4.094M
June 30, 2020 -3.146M
Date Value
March 31, 2020 0.793M
December 31, 2019 7.434M
September 30, 2019 6.384M
June 30, 2019 1.567M
March 31, 2019 -0.683M
December 31, 2018 8.971M
September 30, 2018 0.751M
June 30, 2018 -0.672M
March 31, 2018 -4.575M
December 31, 2017 6.007M
September 30, 2017 3.463M
June 30, 2017 -1.607M
March 31, 2017 -3.052M
December 31, 2016 7.272M
September 30, 2016 7.207M
June 30, 2016 -3.266M
March 31, 2016 -2.356M
December 31, 2015 1.770M
September 30, 2015 4.893M
June 30, 2015 -2.302M
March 31, 2015 -3.281M
December 31, 2014 3.313M
September 30, 2014 4.525M
June 30, 2014 -1.584M
March 31, 2014 -1.605M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Cencora, Inc. 2.654B
Abbott Laboratories 2.488B
Align Technology, Inc. 192.76M
AngioDynamics, Inc. 17.45M
Accuray, Inc. --